An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

NCT01513941 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Telaprevir
DRUG: Ribavirin
DRUG: Pegylated-Interferon-alfa-2a

Sponsor

Janssen-Cilag International NV